Innovation at the Forefront: Angel Yeast Shines at FHA 2024
SINGAPORE, Oct. 24, 2024 /PRNewswire/ -- The FHA 2024 exhibition in Singapore, Asia's largest food and beverage show, is taking place from October 22 to 25, and is generating significant buzz within the hospitality sector. Angel Yeast (SH600298) is showcasing its latest innovations at Booth 3H3-01, featuring cutting-edge yeast technologies and solutions to a...
Besmile Announces RMB 1 Million Donation to Support Shanghai 9th People’s Hospital’s Dental Service Development
SHANGHAI, Oct. 24, 2024 /PRNewswire/ -- Dental service provider Besmile proudly announces a donation of RMB 1 million to Shanghai 9th People's Hospital, reinforcing its commitment to enhancing dental service capabilities within the industry. The fund will help elevate the medical facilities to create a better environment for the patients, meanwhile support academic research and rare disease treatment. ...
Medera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with...
Heart failure is a global pandemic with an estimated 64.3 million cases worldwide, costing over US$100B per year Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart failure cases, but has limited disease-modifying therapeutics Promising efficacy results in cardiovascular performance observed in Cohort A (low-dose SRD-002) at six months with additional data...
SeekIn Presents Cost-Effective Two-Step Multi-Cancer Screening Strategy and Breakthrough Lung Cancer Early Detection Test at Early Detection of Cancer Conference in San Francisco
SAN DIEGO, Oct. 24, 2024 /PRNewswire/ -- SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced today its innovative two-step multi-cancer screening strategy at the Early Detection of Cancer Conference in San Francisco. This approach is designed to significantly alleviate the financial burden of population-wide screening, offering more affordable Multi-Cancer Early Detection (MCED) tests. SeekIn also debuted...
Global Biopharma Thought Leaders Gather in London: Join the 2024 GenScript Biotech Global Forum for Cutting-Edge Insights
PISCATAWAY, N.J., Oct. 24, 2024 /PRNewswire/ -- Cell therapy, gene therapy, and mRNA vaccines are revolutionizing healthcare, offering innovative treatments for a wide range of diseases. However, as these therapies progress, they encounter challenges like safety assessments, cost control, and technological hurdles, underscoring the need for ongoing innovation and industry-wide collaboration. On November 20, 2024, GenScript Biotech will host the...
Botanee & Winona Shines at COSMETIC 360: VOGUE FRANCE, Le Figaro Highlight its Award-Winning Innovations
PARIS, Oct. 24, 2024 /PRNewswire/ -- Winona, a leading cosmeceutical brand in China owned by the Botanee Group, is making its mark on the international stage with groundbreaking plant-based innovations in beauty. Its innovative approach has just earned recognition at COSMETIC 360, the world's leading trade fair for innovations and trends in the perfume and cosmetics industry. In the...
Seegene Holds Partner Executive Roundtable with Microsoft, and Springer Nature, Accelerating its Technology-Sharing Initiative
- The first tri-party executive roundtable was held in London to strengthen synergies for Seegene's vision of creating 'a world free from diseases' - Preliminary results of product development automation and statistical analysis of syndromic test results powered with Microsoft's AI technology were showcased - Global experts and scientists participated in...
The 2024 Seminar on International Communication of Chinese Medicine and Yi Medicine Big Health Industry Development Promotion Conference Held in Chuxiong, Yunnan Province
CHUXIONG, China, Oct. 24, 2024 /PRNewswire/ -- The 2024 Seminar on International Communication of Chinese Medicine and Yi Medicine Big Health Industry Development Promotion Conference was held in Chuxiong, Yunnan Province on October 21. The event was co-sponsored by the China Association of Chinese Medicine, the China Center for International Communication Development of China International Communications Group (CICG), and the...
Pierre Fabre announce 1st Patient Dosed in Phase I/II of PFL-002/VERT-002, a targeted therapy in NSCLC with MET Alterations
Pierre Fabre Laboratories Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-002/VERT-002, an Innovative Targeted Therapy Intended to Treat Non-Small Cell Lung Cancer with MET Alterations PFL-002/VERT-002 is a monoclonal antibody with a novel and differentiated mechanism of action, acting as a degrader of c-MET, with the potential to be a best-in-class treatment for cancer driven by MET...
Founder of Hua Medicine Dr. Li CHEN was awarded the “C.C. Tan Life Science Industrialization Award”
SHANGHAI, Oct. 24, 2024 /PRNewswire/ -- The 17th "C.C. Tan Life Science Award" ceremony was held in Shenyang, China, on October 9th. Dr. Li CHEN, Founder and Chief Executive Officer of Hua Medicine, was awarded the "C.C. Tan Life Science Industrialization Award". C.C. Tan Life Science Award has the highest honor known as "the Chinese Nobel" in life science. "C.C. Tan...
